2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingPhase 32026-05-13NCT06238843
A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapymicrophthalmia, syndromic 9Active, not recruitingPhase 22025-12-05NCT07176702